Hypothesis

In acute arterial injury, a wave of transiently senescent endothelial cells and vascular smooth muscle cells (VSMCs) emerges within the first 48–72 h. These cells secrete a repair‑biased SASP rich in extracellular vesicles (EVs) containing miR‑204 and low‑level IL‑6 that transiently activates Notch1 in neighboring VSMCs, driving a synthetic phenotype needed for extracellular matrix deposition and endothelial progenitor cell (EPC) recruitment. If senescent cells are cleared before this window, the Notch‑mediated VSMC reprogramming and EV‑miR‑204 transfer are blunted, leading to impaired neointima formation and delayed endothelial re‑coverage. Conversely, senolytic administration after the transient phase (day ≥ 5) removes the lingering pro‑inflammatory SASP, reducing arterial stiffness and improving NO bioavailability without compromising repair.

Mechanistic Reasoning

1. EV‑miR‑204 as a Notch modulator – Senescent endothelial EVs deliver miR‑204 to VSMCs, suppressing the Notch inhibitor NUMB and thereby amplifying Notch1 signaling. Notch1 activation promotes VSMC transition from contractile to synthetic state, a process essential for provisional matrix synthesis during wound healing.
2. IL‑6 trans‑signaling threshold – Low‑level IL‑6 (≤10 pg mL⁻¹) engages soluble IL‑6R/gp130 on EPCs, stimulating AKT‑eNOS phosphorylation and enhancing EPC adhesion and tube formation. Higher, chronic IL‑6 levels (>100 pg mL⁻¹) drive VSMC calcification and MMP‑9 mediated matrix degradation.
3. Temporal SASP switch – Early SASP is enriched in EVs and growth factors (VEGF‑A, FGF‑2); late SASP shifts toward pro‑inflammatory cytokines (IL‑1β, TNF‑α) and TGF‑β1, fostering fibrosis. Senolytics selectively remove cells persisting beyond the early window, thus preserving beneficial signals while eliminating detrimental ones.

Testable Predictions

• Prediction 1: In young mice (8‑wk) subjected to femoral artery wire injury, flow‑sorted CD31⁺p16⁺ endothelial cells isolated at 24 h post‑injury will show elevated EV‑miR‑204 content and increased Notch1 intracellular domain (NICD) in co‑cultured VSMCs compared with uninjured controls.
• Prediction 2: Administration of the senolytic ABT‑263 at 0–24 h post‑injury will reduce VSMC NICD levels by ≥40 % and decrease EPC incorporation into the injured endothelium (measured by GFP⁺ bone‑marrow‑derived cells) by ≥35 % relative to vehicle.
• Prediction 3: ABT‑263 given at day 5 post‑injury will not affect early NICD or EPC recruitment but will lower pulse wave velocity (PWV) by ≥15 % and increase acetylcholine‑induced vasodilation by ≥20 % at day 28, indicating improved arterial stiffness without impairing repair.
• Prediction 4: Genetic ablation of p16⁺ cells using p16‑3MR mice, timed with ganciclovir at day 5, will replicate the protective effects of delayed senolytic treatment, whereas early ablation will exacerbate neointimal thinning and endothelial denudation.

Experimental Design

1. Model: Femoral artery wire injury in 8‑wk C57BL/6J mice; parallel cohorts in aged (20‑mo) mice to assess age‑dependent SASP shifts.
2. Interventions: ABT‑263 (50 mg kg⁻¹ i.p.) or vehicle at 0 h, 24 h, 72 h, and day 5 post‑injury; p16‑3MR + ganciclovir for genetic clearance.
3. Readouts:
   • EV isolation from plasma; miR‑204 qPCR.
   • VSMC NICD Western blot; α‑SMA/SMN immunostaining for phenotypic shift.
   • EPC recruitment (GFP⁺ BMDCs) via immunofluorescence.
   • Histological neointima/media ratio (H&E) at day 7 and day 28.
   • Functional assays: PWV, acetylcholine‑induced vasodilation, ex vivo NO production.
4. Analysis: Two‑way ANOVA (treatment × time) with post‑hoc Tukey; n ≥ 8 per group for adequate power.

Falsifiability

If early senolytic clearance (0–24 h) does not diminish VSMC NICD activation, EPC recruitment, or neointima formation, or if delayed clearance (day 5 +) fails to improve PWV or endothelial function, the hypothesis would be refuted. Conversely, confirmation of the predicted temporal dichotomy would support the notion that senescent cells act as transient, beneficial scaffolds during arterial repair, becoming detrimental only when they persist beyond the regenerative window.